News

Ideas That Generate Results

According to a new research report by RNCOS entitled, "Indian Generic Drug Market Outlook 2020", the domestic generic drug market is poised for an impressive growth in near future. According to RNCOS analysis, the market is anticipated to grow with 16.3% CAGR from 2014-2020. The Generics would account for 85% share in the domestic pharma market. With the key initiatives announced by Modi Government to include price control policies, revision of Jan Aushadhi campaign, the market is likely to show notable presence of unbranded drugs. This will further boost players like Sun Pharma, Lupin, Dr. Reddys, and Cipla etc. to generate significant profits from their domestic sales. Other factors such as ongoing patent cliff in the US and Europe and revision of patent laws will help generic manufacturers to capitalize on the unbranded drug market.

Research Analysis and Highlights

The report is spread in over 80 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Indian Generic Drug Market. The report provides a clear picture of the several factors driving the industry growth, and challenges faced by the industry. In addition to this, the study includes several government initiatives to promote unbranded generics. The report further highlights consolidations, regulatory landscape and different players influencing the domestic market. With special emphasis on various government policies, opportunities and recommendations sections, investors will be familiar with the hidden potential of the domestic market.

Some of the key highlights of the report include the following:

           - Ongoing Patent Cliff to push generics drug market
           - Weak supply chain management limiting the generics penetration
           - Revision of Patent Laws to Promote Generic Drug Manufacturers
           - Quality Issues- Biggest Concern for Indian Generics Growth

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM779.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm